Nanoform appoints Antonio da Silva as Chief of Business Operations (CBO) and member of the Management Team
Company release Nanoform Finland Plc December 20th, 2022 15:05 Finnish…
Nanoform CTO Niklas Sandler transitions to technology advisor to the CEO
Company release Nanoform Finland Plc December 20th, 2022 15:05 Finnish…
Nanoform financial calendar for 2023
Company Announcement Nanoform Finland Plc December 7th, 2022 11.00 a.m.…
Nanoform Q3 and 9M 2022 report: Continued solid progress
Highly promising in-vivo data for the treatment of glioblastoma multiforme…
Invitation to Nanoform’s Interim Report January-September 2022
Press release Nanoform Finland Plc November 15, 2022 11:00 a.m.…
Nanoform Finland Plc – Manager’s transactions – Niklas Sandler
Company release Nanoform Finland Plc October 27, 2022 19:15 Finnish…
TargTex to present Tumour Eradication in Rodents from its Nanoformed Glioblastoma drug
Press release Nanoform Finland Plc October 17, 2022 08:10 a.m.…
Nanoform unveils new patient statue
We were delighted to gather the entire Nanoform team for…
Nanoform Finland Plc – Manager’s transactions – Niklas Sandler
Company release Nanoform Finland Plc September 7, 2022 18:00 Finnish…
Share subscriptions based on Nanoform Finland Plc’s stock options 2-3/2019 and 1/2020
Company release Nanoform Finland Plc September 6, 2022 06:00 p.m.…
Nanoform Q2 and H1 2022 report: Strong momentum continues
Company Announcement Nanoform Finland Plc August 25, 2022 08:10 a.m.…
Invitation to Nanoform’s Interim Report January-June 2022
Press release Nanoform Finland Plc August 10th, 2022 11:00 a.m.…
Nanoform and Pharmanovia to breathe new life into iconic medicines
Press release Nanoform Finland Plc July 14th, 2022 08:10 a.m.…
Nanoform Chief of Business Operations Gonçalo Andrade steps down
Company release Nanoform Finland Plc June 13, 2022 18:00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Albert Hæggström
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
Nanoform Finland Plc – Manager’s transactions – Miguel Calado
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
Nanoform Finland Plc – Manager’s transactions – Jeanne Thoma
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
Nanoform Finland Plc – Manager’s transactions – Mads Laustsen
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
Company release Nanoform Finland Plc June 6, 2022 07:30 p.m.…
Nanoform Finland Plc – Manager’s transactions – Miguel Calado
Company release Nanoform Finland Plc June 6, 2022 07:30 p.m.…
Share subscriptions based on Nanoform Finland Plc’s stock options 1-2/2019 and 1/2020
Company release Nanoform Finland Plc June 6, 2022 07:30 p.m.…
Nanoform Finland Plc – Manager’s transactions – Niklas Sandler
Company release Nanoform Finland Plc June 2, 2022 15:45 Finnish…
Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade
Company release Nanoform Finland Plc May 30, 2022 12:30 p.m.…
Nanoform 1Q 2022 report: Quarterly record of new projects and new customers
Company Announcement Nanoform Finland Plc May 24, 2022 08:10 a.m.…
Invitation to Nanoform’s Interim Report January-March 2022
Press release Nanoform Finland Plc May 10th, 2022 11:00 a.m.…
Nanoform launches “STARMAP® Online” placing AI-power at the fingertips of medicine developers
Press release Nanoform Finland Plc May 4th, 2022 09:00 a.m.…
Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade
Company release Nanoform Finland Plc April 12, 2022 07:05 p.m.…
Nanoform Finland Plc – Manager’s transactions – Niklas Sandler
Company release Nanoform Finland Plc April 12, 2022 07:05 p.m.…
Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs
Company release Nanoform Finland Plc April 12, 2022 07:00 p.m.…
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Company release Nanoform Finland Plc April 12, 2022 07:00 p.m.…
Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 12, 2022
Company release Nanoform Finland Plc April 12, 2022 12:30 p.m.…
Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade
Company release Nanoform Finland Plc March 25, 2022 04.45 p.m.…
New shares of Nanoform registered with the trade register
New shares of Nanoform registered with the trade register March…
Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA
Inside information Nanoform Finland Plc March 22, 2022 23:45 Finnish…
Nanoform announces its intention to carry out a new share issue to raise approximately EUR 25 million to prepare for GMP manufacturing in the USA
Inside information Nanoform Finland Plc March 22, 2022 18:31 Finnish…
Notice to the Annual General Meeting of NANOFORM FINLAND Plc
The shareholders of Nanoform Finland Plc (the “Company”) (business ID:…
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen
Nanoform Finland Oyj:n (”Yhtiö”) (Y-tunnus: 2730572-8) osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen,…
Nanoform triples its GMP capacity and adds high potent handling (OEL <30 ng/m3) capabilities to its Helsinki facility to meet increasing demand.
In today’s pharmaceutical development pipeline, about 70% to 90% of…
Nanoform 4Q and full year 2021 report: accelerating GMP growth
Company Announcement Nanoform Finland Plc February 22, 2022 08:10 a.m.…
Invitation to Nanoform’s Q4 and full year 2021 report February 22, 2022
Press release Nanoform Finland Plc February 8, 20212 11:00 a.m.…
Nanoform signs GMP manufacturing program with TargTex following formulation success
Press release Nanoform Finland Plc February 4, 2022 08:10 a.m.…
Nanoform sets two new near-term business targets for 2022
Insider information Nanoform Finland Plc January 3, 2022 08:10 a.m.…